• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A case of ventricular asystole without escape rhythm 4 days after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy with drug-resistant paroxysmal atrial fibrillation.肥厚型梗阻性心肌病伴药物难治性阵发性心房颤动患者经皮腔内室间隔心肌消融术后4天出现无逸搏心律的心室停搏1例。
J Cardiol Cases. 2011 Aug 11;4(2):e110-e114. doi: 10.1016/j.jccase.2011.07.002. eCollection 2011 Oct.
2
Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.肥厚性梗阻性心肌病患者经皮腔内室间隔心肌消融术后左心室的早期重塑及心肌性能改善
Int J Cardiol. 2003 Mar;88(1):27-32. doi: 10.1016/s0167-5273(02)00381-9.
3
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.经皮腔内室间隔心肌消融术治疗肥厚型梗阻性心肌病:25例患者的急性结果及3个月随访
J Am Coll Cardiol. 1998 Feb;31(2):252-8. doi: 10.1016/s0735-1097(97)00508-1.
4
Real-world clinical outcomes of percutaneous transluminal septal myocardial ablation for patients with drug-refractory hypertrophic obstructive cardiomyopathy: results from a retrospective multicenter registry of non-high-volume centers.经皮腔内室间隔心肌消融术治疗药物难治性肥厚型梗阻性心肌病的真实世界临床结局:来自非高容量中心回顾性多中心登记处的结果。
Heart Vessels. 2022 Nov;37(11):1937-1946. doi: 10.1007/s00380-022-02100-4. Epub 2022 May 31.
5
Percutaneous transluminal septal myocardial ablation: past, present, and future.经皮腔内室间隔心肌消融术:过去、现在和未来。
J Cardiol. 2022 Sep;80(3):211-217. doi: 10.1016/j.jjcc.2021.11.023. Epub 2021 Dec 16.
6
[Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results in 66 patients with reference to myocardial contrast echocardiography].[经皮腔内室间隔心肌消融术治疗肥厚型梗阻性心肌病:66例患者的急性结果及心肌对比超声心动图分析]
Z Kardiol. 1998 Mar;87(3):191-201. doi: 10.1007/s003920050171.
7
Percutaneous Transluminal Septal Myocardial Ablation for Hypertrophic Obstructive Cardiomyopathy Under Extracorporeal Membrane Oxygenation Support.体外膜肺氧合支持下经皮腔内室间隔心肌消融术治疗肥厚型梗阻性心肌病
JACC Case Rep. 2020 Oct 21;2(12):1917-1922. doi: 10.1016/j.jaccas.2020.07.062. eCollection 2020 Oct.
8
Percutaneous transluminal septal myocardial ablation in drug-resistant hypertrophic obstructive cardiomyopathy: 18-month follow-up results.经皮腔内室间隔心肌消融术治疗药物难治性肥厚型梗阻性心肌病:18个月随访结果
J Invasive Cardiol. 2001 Jul;13(7):526-30.
9
Intravenous myocardial contrast echocardiography can predict recurrence of pressure gradient of left ventricular outflow tract in hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation.静脉心肌对比超声心动图可预测肥厚型梗阻性心肌病经皮腔内室间隔心肌消融术后左心室流出道压力阶差的复发情况。
J Cardiol Cases. 2009 Nov 8;1(1):e25-e27. doi: 10.1016/j.jccase.2009.06.005. eCollection 2010 Feb.
10
Percutaneous transluminal septal myocardial ablation (PTSMA) for symptomatic patients with hypertrophic obstructive cardiomyopathy: first experience.经皮腔内室间隔心肌消融术(PTSMA)治疗症状性肥厚型梗阻性心肌病患者:初步经验。
Neth Heart J. 2001 Nov;9(8):318-321.

本文引用的文献

1
Percutaneous transluminal septal myocardial ablation (PTSMA) for symptomatic patients with hypertrophic obstructive cardiomyopathy: first experience.经皮腔内室间隔心肌消融术(PTSMA)治疗症状性肥厚型梗阻性心肌病患者:初步经验。
Neth Heart J. 2001 Nov;9(8):318-321.
2
Percutaneous septal ablation: a new treatment for hypertrophic obstructive cardiomyopathy.经皮室间隔消融术:肥厚型梗阻性心肌病的一种新治疗方法。
Neth Heart J. 2001 Nov;9(8):315-317.
3
Impact of percutaneous transluminal septal myocardial ablation on refractory paroxysmal atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy.
Angiology. 2008 Jun-Jul;59(3):329-34. doi: 10.1177/0003319707305406. Epub 2008 Apr 2.
4
Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy.完全性心脏传导阻滞:肥厚型梗阻性心肌病患者接受非手术性室间隔减容治疗的决定因素及临床影响
J Am Coll Cardiol. 2003 Jul 16;42(2):296-300. doi: 10.1016/s0735-1097(03)00623-5.
5
Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients.经皮腔内室间隔心肌消融术治疗肥厚性梗阻性心肌病:首批25例患者的长期随访
Heart. 2000 Mar;83(3):326-31. doi: 10.1136/heart.83.3.326.
6
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography.肥厚型梗阻性心肌病经皮腔内室间隔心肌消融术:关于术中心肌对比超声心动图的结果
Circulation. 1998 Dec 1;98(22):2415-21. doi: 10.1161/01.cir.98.22.2415.
7
Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy.超声心动图引导下乙醇间隔消融术治疗肥厚型梗阻性心肌病
Circulation. 1998 Oct 27;98(17):1750-5. doi: 10.1161/01.cir.98.17.1750.
8
Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients.肥厚型梗阻性心肌病的非手术性室间隔减容术:首批患者的治疗结果
Circulation. 1997 Apr 15;95(8):2075-81. doi: 10.1161/01.cir.95.8.2075.
9
Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy.肥厚性梗阻性心肌病的非手术性心肌减容术
Lancet. 1995 Jul 22;346(8969):211-4. doi: 10.1016/s0140-6736(95)91267-3.

肥厚型梗阻性心肌病伴药物难治性阵发性心房颤动患者经皮腔内室间隔心肌消融术后4天出现无逸搏心律的心室停搏1例。

A case of ventricular asystole without escape rhythm 4 days after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy with drug-resistant paroxysmal atrial fibrillation.

作者信息

Ohtsubo Mitsunori, Sakai Hiroto, Kon Hisashi, Takano Hideyuki

机构信息

Division of Cardiology, Hokkaido Chuo Rosai Hospital, Iwamizawa, Hokkaido, Japan.

出版信息

J Cardiol Cases. 2011 Aug 11;4(2):e110-e114. doi: 10.1016/j.jccase.2011.07.002. eCollection 2011 Oct.

DOI:10.1016/j.jccase.2011.07.002
PMID:30532876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6265096/
Abstract

A 42-year-old man with a more than 10-year history of hypertrophic obstructive cardiomyopathy, but no history of heart failure or syncope, had left ventricular outflow tract pressure gradient (LVOT-PG) of 50-80 mmHg on Doppler echocardiography. In June 2010, he experienced general malaise on effort, and LVOT-PG increased to 124 mmHg. Two months later, he suffered a transient ischemic attack, complicated with atrial fibrillation (AF). He underwent cardiac defibrillation and was prescribed amiodarone, but the arrhythmia recurred easily. Therefore, percutaneous transluminal septal myocardial ablation (PTSMA) was performed to prevent AF. The procedure entailed transient complete atrioventricular block (CAVB), which was resolved after a few hours. Four days later, CAVB recurred and advanced to fatal ventricular asystole without escape rhythm. The patient was resuscitated instantaneously and recovered without brain damage. Finally, a DDD permanent pacemaker was implanted 10 days after the procedure. Except for conduction problems, his cardiac condition was good after PTSMA, as paroxysmal AF disappeared and LVOT-PG was markedly decreased. CAVB is a well-known complication of PTSMA, but fatal ventricular asystole several days after the procedure is rare. Intensive care is required after PTSMA implementation.

摘要

一名42岁男性,有超过10年的肥厚性梗阻性心肌病病史,但无心力衰竭或晕厥病史,经多普勒超声心动图检查,左心室流出道压力阶差(LVOT-PG)为50 - 80 mmHg。2010年6月,他在用力时出现全身不适,LVOT-PG增至124 mmHg。两个月后,他发生短暂性脑缺血发作,并并发心房颤动(AF)。他接受了心脏除颤治疗,并服用胺碘酮,但心律失常很容易复发。因此,为预防AF进行了经皮腔内室间隔心肌消融术(PTSMA)。该手术导致短暂性完全性房室传导阻滞(CAVB),数小时后恢复。四天后,CAVB复发并进展为致命性心室停搏,无逸搏心律。患者立即复苏且未遗留脑损伤而康复。最后,在手术后10天植入了DDD永久性起搏器。除传导问题外,PTSMA术后他的心脏状况良好,阵发性AF消失,LVOT-PG明显降低。CAVB是PTSMA的一种已知并发症,但术后数天出现致命性心室停搏很少见。实施PTSMA后需要重症监护。